By Kamal Choudhury Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical ...
Hosted on MSN
We tried the Flow Neuroscience tDCS kit for 10 weeks
According to ONS data from April 2025, 18 per cent of all adults in the UK suffered moderate to severe depressive symptoms. Figures from the Priory Group suggest that, in any given week, one in six ...
The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side ...
WASHINGTON — The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results